Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report)’s share price dropped 3.8% during trading on Friday . The stock traded as low as $10.81 and last traded at $10.78. Approximately 201,759 shares ...

Vir Biotechnology Inc (VIR) stock saw a modest uptick, ending the day at $11.2 which represents a slight increase of $0.67 or 6.36% from the prior close of $10.53. The stock opened at $10.48 and ...

We recently compiled a list of the Why These 15 Stocks Are Skyrocketing in 2025. In this article, we are going to take a look at where Vir Biotechnology, Inc. (NASDAQ:VIR) stands against the other ...

At the conference last week in San Francisco, pharmaphorum editor-in-chief Jonah Comstock spoke with Vir Biotechnology CEO ...

A trial exploring the use of a higher dose of Novo Nordisk's GLP-1 agonist semaglutide has shown that patients with obesity ...

Vir Biotechnology, Inc. (NASDAQ:VIR – Get Free Report) has earned a consensus recommendation of “Moderate Buy” from the six ...

With new legislation and noteworthy policies on sci-tech and innovation expected this year, businesses are hoping the right ...

China Medical University and Healthcare System hosted the International Forum of Extracellular Vesicles Technology and Novel ...

Bank of America Securities analyst Alec Stranahan maintained a Hold rating on Vir Biotechnology (VIR – Research Report) yesterday and set a ...

Leerink Partners analyst Roanna Ruiz reiterated a Buy rating on Vir Biotechnology (VIR – Research Report) on January 13 and set a price target ...

Rep. Virginia Foxx has been named chairwoman of one of the most powerful committees in Congress. On Tuesday morning, House Speaker Mike Johnson announced he chose Foxx to lead the House Committee ...

Are dogs really the key to better health and a happier life? In a new study, appearing in Scientific Reports, dog owners were invited to describe the biggest benefits and challenges of dog ...